Cargando…

Cytokine signatures in chronic fatigue syndrome patients: a Case Control Study and the effect of anakinra treatment

BACKGROUND: Cytokine disturbances have been suggested to be associated with the Chronic Fatigue Syndrome/Myalgic encephalomyelitis (CFS/ME) for decades. METHODS: Fifty female CFS patients were included in a study on the effect of the interleukin-1-receptor antagonist anakinra or placebo during 4 wee...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roerink, Megan E., Knoop, Hans, Bronkhorst, Ewald M., Mouthaan, Henk A., Hawinkels, Luuk J. A. C., Joosten, Leo A. B., van der Meer, Jos W. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5747240/ https://www.ncbi.nlm.nih.gov/pubmed/29284500 http://dx.doi.org/10.1186/s12967-017-1371-9

Ejemplares similares

Cytokine inhibition in chronic fatigue syndrome patients: study protocol for a randomized controlled trial
por: Roerink, Megan E., et al.
Publicado: (2015)

No Signs of Neuroinflammation in Women With Chronic Fatigue Syndrome or Q Fever Fatigue Syndrome Using the TSPO Ligand [(11)C]-PK11195
por: Raijmakers, Ruud, et al.
Publicado: (2021)

Interleukin-1 as a mediator of fatigue in disease: a narrative review
por: Roerink, Megan E., et al.
Publicado: (2017)

Central delivery of iodine-125–labeled cetuximab, etanercept and anakinra after perispinal injection in rats: possible implications for treating Alzheimer’s disease
por: Roerink, Megan E., et al.
Publicado: (2015)

Multi-omics examination of Q fever fatigue syndrome identifies similarities with chronic fatigue syndrome
por: Raijmakers, Ruud P. H., et al.
Publicado: (2020)

A possible role for mitochondrial-derived peptides humanin and MOTS-c in patients with Q fever fatigue syndrome and chronic fatigue syndrome
por: Raijmakers, Ruud P. H., et al.
Publicado: (2019)

Investigating neural mechanisms of change of cognitive behavioural therapy for chronic fatigue syndrome: a randomized controlled trial
por: van Der Schaaf, Marieke E, et al.
Publicado: (2015)

Clinical assessment of the physical activity pattern of chronic fatigue syndrome patients: a validation of three methods
por: Scheeres, Korine, et al.
Publicado: (2009)

Intravenous anakinra for cytokine storm syndromes
por: Jamilloux, Yvan, et al.
Publicado: (2020)

A possible link between recurrent upper respiratory tract infections and lower cytokine production in patients with Q fever fatigue syndrome
por: Raijmakers, Ruud P.H., et al.
Publicado: (2019)

Intravenous anakinra for cytokine storm syndromes – Authors' reply
por: Mehta, Puja, et al.
Publicado: (2020)

Effect of In Vitro and In Vivo Anakinra on Cytokines Production in Schnitzler Syndrome
por: Launay, David, et al.
Publicado: (2013)

Cytokine storm and use of anakinra in a patient with COVID-19
por: Nemchand, Priyanka, et al.
Publicado: (2020)

The Qure study: Q fever fatigue syndrome – response to treatment; a randomized placebo-controlled trial
por: Keijmel, Stephan P, et al.
Publicado: (2013)

Early identification of COVID-19 cytokine storm and treatment with anakinra or tocilizumab
por: Langer-Gould, Annette, et al.
Publicado: (2020)

Acute Cytokine Response During Breast Cancer Surgery: Potential Role of Dexamethasone and Lidocaine and Relationship with Postoperative Pain and Complications – Analysis of Three Pooled Pilot Randomized Controlled Trials
por: van den Heuvel, Sandra A S, et al.
Publicado: (2020)

Continuous Intravenous Anakinra Infusion to Calm the Cytokine Storm in Macrophage Activation Syndrome
por: Monteagudo, Luke Adam, et al.
Publicado: (2020)

Assessing fatigue in childhood cancer survivors: Psychometric properties of the Checklist Individual Strength and the Short Fatigue Questionnaire––a DCCSS LATER study
por: Penson, Adriaan, et al.
Publicado: (2021)

Inflammasome-Independent Modulation of Cytokine Response by Autophagy in Human Cells
por: Crişan, Tania O., et al.
Publicado: (2011)

Rapid Response to Cytokine Storm Inhibition Using Anakinra in a Patient With COVID-19 Myocarditis
por: Trpkov, Cvetan, et al.
Publicado: (2020)

Silencing the cytokine storm: the use of intravenous anakinra in haemophagocytic lymphohistiocytosis or macrophage activation syndrome
por: Mehta, Puja, et al.
Publicado: (2020)

Use of Intravenous Anakinra for Management of Pediatric Cytokine Storm Syndromes at an Academic Medical Center
por: Yang, Lirong, et al.
Publicado: (2023)

Interferon-γ and CXCL10 responses related to complaints in patients with Q fever fatigue syndrome
por: Raijmakers, Ruud P. H., et al.
Publicado: (2018)

Methodology of the DCCSS later fatigue study: a model to investigate chronic fatigue in long-term survivors of childhood cancer
por: Penson, Adriaan, et al.
Publicado: (2021)

PW03-018 – Efficacy of Anakinra in recurrent pericarditis
por: Finetti, M, et al.
Publicado: (2013)

Evolution of cytokine production capacity in ancient and modern European populations
por: Domínguez-Andrés, Jorge, et al.
Publicado: (2021)

The effect of Anakinra on Quality-of-Life in a family with colchicine-resistant FMF
por: van der Hilst, J, et al.
Publicado: (2015)

Anakinra for patients with COVID-19
por: Maoujoud, Omar, et al.
Publicado: (2020)

Anakinra for patients with COVID-19
por: Valette, Xavier, et al.
Publicado: (2020)

Anakinra for patients with COVID-19
por: Martin-Silva, Nicolas, et al.
Publicado: (2020)

Effect of anakinra in COVID-19
por: Kooistra, Emma J, et al.
Publicado: (2020)

Anakinra: Jaundice: case report
Publicado: (2021)

Continuous IV infusion of anakinra
por: Saunders, Brittney N., et al.
Publicado: (2023)

The Effect of Acclydine in Chronic Fatigue Syndrome: A Randomized Controlled Trial
por: The, Gerard K. H, et al.
Publicado: (2007)

P03-019 - Anakinra for sweet syndrome treatment
por: Passaro, G, et al.
Publicado: (2013)

Anakinra Therapy for Non-cancer Inflammatory Diseases
por: Cavalli, Giulio, et al.
Publicado: (2018)

An open label trial of anakinra to prevent respiratory failure in COVID-19
por: Kyriazopoulou, Evdoxia, et al.
Publicado: (2021)

Prevalence and risk factors of cancer‐related fatigue in childhood cancer survivors: A DCCSS LATER study
por: van Deuren, Sylvia, et al.
Publicado: (2021)

Anakinra in COVID-19: important considerations for clinical trials
por: King, Andrew, et al.
Publicado: (2020)

Blended versus face-to-face cognitive behavioural therapy for severe fatigue in patients with multiple sclerosis: A non-inferiority RCT
por: de Gier, Marieke, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bqv3861b2koqgj2tjd29eg9vmi